The birth of a child with developmental eye anomalies can be devastating for families, bringing with it uncertainties about vision, other medical complications, and possible recurrence in future offspring.
Funding our eye genetics research programme is so important to help children and families affected with these conditions, not just in our programme but also worldwide. By improving early diagnosis, treatment and support, we can transform people’s lives.
Our improved understanding of these genes and pathways is already leading to better understanding of genetic mechanisms, and will lead to advances in ways to prevent blindness and sight-saving therapies.
With your help, we could expand our team to build a dedicated centre for holistic care, integrated with world-class research, to support families across the UK and globally, affected by severe genetic eye anomalies. We would be delighted for you to be a part of realising our vision to support.
Read our Case for Support
Professor Nicola Ragge, Baillie Gifford Professor of Developmental Eye Genetics, Department of Biological and Medical Sciences, Oxford Brookes University and Consultant Geneticist, Birmingham Women's and Children's NHS Foundation Trust.
Professor Nicky Ragge
The Vision for GoOD (Genetics of Ocular Development) research group at Oxford Brookes brings together clinicians (geneticists, ophthalmologists, counselors, family support) and research scientists (genetics, psychology) to provide comprehensive, cross-disciplinary therapeutic strategies and care for families.
Our team, led by Professor Nicky Ragge, includes scientific researchers, family liaison and counsellors.
Read more about the scientific research we are working on
Professor Nicky Ragge, together with Professor Patrick Calvas and Dr Nicolas Chassaing founded the GoOD network which brings together clinicians (geneticists and ophthalmologists) and scientists worldwide.
(Photo shows delegates to the inaugural 2019 meeting in Oxford, England)
The GoOD network brings together clinicians (geneticists and ophthalmologists) and scientists worldwide to share ideas for the diagnosis of genetic eye disease, an understanding of the conditions, including phenotypes, inheritance patterns and the basic pathways involved, and to determine future strategies in terms of therapeutics.
It allows basic scientists involved in the research of these eye anomalies and clinicians involved in the care of such individuals with developmental eye genetic disorders to meet, listen to each others’ interesting work and collaborate.
A break for delegates during the Toulouse, France 2023 meeting
Our research group at Oxford Brookes is seeking £3 m to underpin our research and core support to families for the next 5 years.
We are exploring a further goal of a state-of-the-art facility for research, rapid benchside diagnosis, therapeutic approaches, and family support,
target £17 m.
